The new launches include the 80/160-slice computed tomography (CT) scanner Aquilion Serve, which allows simultaneous previews of axial, lateral and AP views, and Celex, a multipurpose X-ray system that offers automated and customizable features to help maximize workflow efficiencies.
With an eye toward enhanced image quality and artificial intelligence (AI)-automated features to maximize workflow efficiencies, Canon Medical debuted the Aquilion Serve computed tomography (CT) and the Celex multipurpose X-Ray systems at the European Congress of Radiology (ECR) in Vienna, Austria.
The Aquilion Serve’s combination of the 3D Landmark Scan and Anatomical Landmark Detection features enable automated scan planning for routine CT examinations, according to Canon Medical. In order to ensure consistent CT scans, the company said the Aquilion Serve allows clinicians to establish automated positioning as per scanning protocols to ensure optimal scan range and field of view. Acquired at the same dose as a dual scanogram, the 3D Landmark Scan enables concurrent previews of axial, lateral and AP views.
Canon Medical said other features of the Aquilion Serve include the Advanced intelligent Clear-IQ Engine (AiCE), which utilizes deep learning to produced enhanced CT image quality, and INSTINX, a workflow solution that combines an intuitive user experience with AI-powered automation options.
Enhanced automation also factors into the features for the Celex digital radiography system. Canon Medical says Celex allows clinicians to save nearly 1,000 unique auto-positions for clinical procedures and has an “inMotion” technology that provides automated detector and tube positioning to preset parameters for examinations.
In addition to a carbon fiber patient table, the Celex device is comprised of materials that minimize X-ray absorption, facilitating optimal dosing reduction, according to Canon Medical. The company said advanced software with the Celex system has algorithms to address noise reduction and edge enhancement as well as programs to help ensure minimal dosing for pediatric patients.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.